The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer

Information about The KRAS-Variant Is Associated with Risk of Developing Double Primary...

Published on November 9, 2014

Author: MiraKind

Source: slideshare.net

Description Content

A germline microRNA binding site-disrupting variant, the KRAS-variant (rs61764370), is associated with an increased risk of developing several cancers. Because this variant is most strongly associated with ovarian cancer risk in patients from hereditary breast and ovarian families (HBOC), and with the risk of premenopausal triple negative breast cancer, we evaluated the association of the KRAS-variant with women with personal histories of both breast and ovarian cancer, referred to as double primary patients.

Related presentations


Other presentations created by MiraKind

MiraKind Breast Cancer Awareness
09. 11. 2014
0 views

MiraKind Breast Cancer Awareness

MiraKind 6 and 25 percent banner
09. 11. 2014
0 views

MiraKind 6 and 25 percent banner